NEWPORT BEACH, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) -- BUYINS.NET, http://www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Amarantus BioSciences (OTCBB:AMBS) after releasing the latest short sale data through November 9, 2012. The total aggregate number of shares shorted since June 2011 is approximately 158 million shares. Approximately 27.32% of daily trading volume is short selling. The SqueezeTrigger price for all AMBS shares shorted is $0.036. A short squeeze has begun as AMBS is above its $0.036 SqueezeTrigger Price.

Click for original Report: http://www.buyins.com/reports/ambs11-2-12.pdf

Click for updated SqueezeTrigger: http://www.buyins.com/images2/ambsstr11-11-12.jpg

Click for updated Friction Factor: http://www.buyins.com/images2/ambsff11-11-12.jpg

Friction Factor calculates if a fair market is being made in the shares of AMBS. 59% of the previous 37 trading days have been positive or bullish-biased and 41% have been negative or bearish-biased.

Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies or investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.